Elaine Jones V

US·SEC (Form 4)

CytomX Therapeutics, Inc.Gyre Therapeutics, Inc.

Cumul. flow

Total declarations

Companies

▲ Purchases (1 ops.)

€7,147

▼ Sales (0 ops.)

—

Latest filing published 31 Mar 2023 for CytomX Therapeutics, Inc., €7,147.

Filing timeline

BuySale

Elaine Jones V

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

CytomX Therapeutics, Inc. 1 purchase · last 31 Mar 2023

Since each purchase

CytomX Therapeutics, Inc.
Filed 31 Mar 2023 · 1305 days ago · €7,147
+39.6%
Entry US$1.54 · Close at T+365 US$2.15

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Elaine Jones V: trading record in brief

This profile gathers the share dealings of Elaine Jones V across 2 companies, led by Gyre Therapeutics, Inc. and CytomX Therapeutics, Inc. Between 18 April 2006 and 29 March 2023, the trades on record add up to 15 filings.

The open-market record is one-sided, with 1 purchase worth €7,147 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 6 share grants and 3 option exercises. In 2023 alone, the filings show 1 purchase and no sales.

The record was last updated on 31 March 2023 with an open-market purchase (€7,147) in CytomX Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.